The Boston Globe

Business

Boston.com

Cubist officially opens expanded R&D facility

By Chris Reidy

 |  Globe Staff  

  March 16, 2012

Cubist Pharmaceuticals Inc. said Friday that it has officially opened its expanded research and development facility at its headquarters in Lexington. The 104,000 square-foot expansion includes state-of-the art laboratory space for R&D around antibiotics and other acute care products, a molecular modeling room, office space, and conference rooms. Cubist makes a drug called Cubicin, which treats skin and bloodstream infections. The company had revenue of $754 million last year.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help